Related Experiment Video
Updated: Jun 4, 2026

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery
Kaylin M McMahon1, R Kannan Mutharasan, Sushant Tripathy
1Department of Urology, Feinberg School of Medicine, Northwestern University , 303 East Chicago Avenue, Tarry 16-703, Chicago, Illinois 60611, United States.
Abstract:
We report a gold nanoparticle-templated high density lipoprotein (HDL AuNP) platform for gene therapy that combines lipid-based nucleic acid transfection strategies with HDL biomimicry. For proof-of-concept, HDL AuNPs are shown to adsorb antisense cholesterylated DNA. The conjugates are internalized by human cells, can be tracked within cells using transmission electron microscopy, and regulate target gene expression. Overall, the ability to directly image the AuNP core within cells, the chemical tailorability of the HDL AuNP platform, and the potential for cell-specific targeting afforded by HDL biomimicry make this platform appealing for nucleic acid delivery.

